Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) ; volume:3 ; number:1 ; day:22 ; month:12 ; year:2015 ; pages:129-141 ; date:6.2016
Rheumatology and therapy ; 3, Heft 1 (22.12.2015), 129-141, 6.2016
- Urheber
-
Koike, Takao
- Beteiligte Personen und Organisationen
-
Harigai, Masayoshi
Ishiguro, Naoki
Inokuma, Shigeko
Takei, Syuji
Takeuchi, Tsutomu
Yamanaka, Hisashi
Takasaki, Yoshinari
Mimori, Tsuneyo
Hiramatsu, Katsutoshi
Komatsu, Shuichi
Tanaka, Yoshiya
SpringerLink (Online service)
- DOI
-
10.1007/s40744-015-0023-x
- URN
-
urn:nbn:de:1111-2016062210675
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koike, Takao
- Harigai, Masayoshi
- Ishiguro, Naoki
- Inokuma, Shigeko
- Takei, Syuji
- Takeuchi, Tsutomu
- Yamanaka, Hisashi
- Takasaki, Yoshinari
- Mimori, Tsuneyo
- Hiramatsu, Katsutoshi
- Komatsu, Shuichi
- Tanaka, Yoshiya
- SpringerLink (Online service)
Ähnliche Objekte (12)
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry